1st June, 2023

Impact Innovation Cohort 7

Mindplus AI has been accepted into the Hong Kong Science Park Ideation Programme. This prestigious program will provide one year of startup support to Mindplus AI, enabling the company to further develop its innovative solution in the field of ophthalmology.

The Ideation Programme aims to nurture technology-focused entrepreneurs and provide comprehensive support to startups, helping them turn great ideas into reality. Through this program, Mindplus AI will receive HK$100,000 in seed funding, guidance from experienced mentors, and training courses covering topics such as business models and investment pitching. Additionally, the company will have access to Hong Kong Science Park’s advanced co-working space, preparing them for future incubation opportunities.

Mindplus AI is thrilled to be selected as a member of the Hong Kong Science Park Ideation Programme. This is a rare opportunity for us to further develop our AI solution in ophthalmology, with the goal of improving the accuracy and efficiency of Optical Coherence Tomography (OCT) diagnosis. With the support and resources provided by Hong Kong Science Park, we are confident in making a significant impact in the healthcare industry.

Mindplus AI’s innovative solution utilizes artificial intelligence and deep learning technology to assist medical professionals in identifying abnormal OCT images and focusing on key regions. By reducing the waiting time between imaging and diagnosis, the company aims to address the existing problem of long waiting times and a shortage of ophthalmologists in Hong Kong. Their solution initially focuses on the three most common eye disorders: Age-Related Macular Degeneration, Glaucoma, and Diabetic Macular Edema.

Being selected for the Ideation Programme is a significant milestone for Mindplus AI, and we will continue to strive for excellence in the field of medical technology. With the support of Hong Kong Science Park, Mindplus AI plans to further optimize their AI algorithms, expand their dataset, and explore collaborations with medical institutions, ultimately making a contribution to the healthcare industry in Hong Kong and beyond.